AU Patent

AU2014211856C1 — Substituted 2-aminopyridine protein kinase inhibitor

Assigned to Centaurus Biopharma Co Ltd · Expires 2018-04-12 · 8y expired

What this patent protects

Disclosed are a 2-aminopyridine derivative having protein kinase inhibition activity, preparation method and pharmaceutical composition thereof. Also disclosed are uses of the compound and the pharmaceutical composition thereof in the preparation of drugs for treating and/or prev…

USPTO Abstract

Disclosed are a 2-aminopyridine derivative having protein kinase inhibition activity, preparation method and pharmaceutical composition thereof. Also disclosed are uses of the compound and the pharmaceutical composition thereof in the preparation of drugs for treating and/or preventing protein kinase-related diseases.

Drugs covered by this patent

Patent Metadata

Patent number
AU2014211856C1
Jurisdiction
AU
Classification
—
Expires
2018-04-12
Drug substance claim
No
Drug product claim
No
Assignee
Centaurus Biopharma Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.